MINDACT: adjuvant chemotherapy in breast cancer
Автор: VJOncology
Загружено: 2020-05-30
Просмотров: 1415
Описание: Emiel Rutgers, MD, PhD, FRCS, Netherlands Cancer Institute, Amsterdam, tells us about the long-term results of the MINDACT study (NCT00433589). This large prospective trial tested the 70-gene signature, MammaPrint, to guide the use of adjuvant chemotherapy in breast cancer patients. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: